Sponsor of the Day:
Jerkmate
https://www.news-medical.net/news/20260417/Circulating-exosomal-microRNAs-offer-a-non-invasive-biomarker-for-MASLD.aspx
Circulating exosomal microRNAs offer a non-invasive biomarker for MASLD
Metabolic dysfunction-associated steatotic liver disease (MASLD) has become a global public health challenge with rapidly rising prevalence, especially in...
non invasivecirculatingmicrornasofferbiomarker
https://www.news-medical.net/whitepaper/20260417/Rethinking-early-phase-MASLD-trials.aspx
Rethinking early-phase MASLD trials
Explore new approaches to early-phase MASLD trials, addressing metabolic complexity and improving clinical relevance in study design.
early phaserethinkingmasldtrials
https://cdhf.ca/en/digestive-conditions/metabolic-dysfunction-associated-steatotic-liver-disease-masld/
Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) - Canadian Digestive Health...
Jan 6, 2026 - Learn about MASLD and MASH, previously known as non-alcoholic fatty liver disease (NAFLD).
steatotic liver diseasecanadian digestive healthmetabolicmasld
https://www.jci.org/articles/view/198334
JCI - The pathogenesis of hepatic steatosis in MASLD: a lipid droplet perspective
jcipathogenesishepaticmasldlipid
https://www.cme-kurs.de/kurse/leberfibrose-bei-fettleber-masld-in-der-praxis-erkennen
Leberfibrose bei Fettleber/MASLD in der Praxis erkennen
May 5, 2026 - Fortbildung mit 4 CME-Punkten. Die Diagnostik der metabolischen Dysfunktion-assoziierten steatotischen Lebererkrankung (MASLD) hat durch die breite...
der praxisbeifettlebermaslderkennen
https://www.jci.org/articles/view/189953
JCI - Disease classification, diagnostic challenges, and evolving clinical trial design in MASLD
clinical trial designjcidiseaseclassificationdiagnostic
https://www.news-medical.net/news/20260423/Study-identifies-key-risk-factors-driving-MASLD-across-populations.aspx
Study identifies key risk factors driving MASLD across populations
Metabolic dysfunction-associated steatotic liver disease (MASLD) affects approximately 32% of the US adult population.
study identifieskey riskfactors drivingmasldacross
https://www.jci.org/articles/view/186421
JCI - Dissecting the mechanisms of MASLD fibrosis in the era of single-cell and spatial omics
single cellspatial omicsjcidissectingmechanisms